MBX Biosciences MBX is set to give its latest quarterly earnings report on Thursday, 2025-08-07. Here's what investors need to know before the announcement.
Analysts estimate that MBX Biosciences will report an earnings per share (EPS) of $-0.76.
The announcement from MBX Biosciences is eagerly anticipated, with investors seeking news of surpassing estimates and favorable guidance for the next quarter.
It's worth noting for new investors that guidance can be a key determinant of stock price movements.
Earnings History Snapshot
Last quarter the company beat EPS by $0.06, which was followed by a 7.81% drop in the share price the next day.
Here's a look at MBX Biosciences's past performance and the resulting price change:
| Quarter | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
|---|---|---|---|---|
| EPS Estimate | -0.76 | -0.77 | -0.58 | |
| EPS Actual | -0.58 | -0.71 | -0.47 | -2.78 |
| Price Change % | 9.0% | -8.0% | -5.0% | -1.0% |
Tracking MBX Biosciences's Stock Performance
Shares of MBX Biosciences were trading at $12.53 as of August 12. Over the last 52-week period, shares are down 44.44%. Given that these returns are generally negative, long-term shareholders are likely a little upset going into this earnings release.
To track all earnings releases for MBX Biosciences visit their earnings calendar on our site.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
Edge Rankings
Price Trend
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
